Impact of Catch-up HPV Vaccination (HPVAC2)

Regional University Hospital Center (CHRU)

Status: Terminated

Conditions: Vaccine Preventable Disease; HPV Vaccination; HPV; Cervical Lesion; Cervical Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT05462249

HPVAC2 - 29BRC21.0008

Details and patient eligibility

About

Each year in France, more than 6000 new cases of HPV inducted cancers are recorded. The vaccinal cover stays insufficient since less than 30% of the french population is vaccinated. Therefore french studies about vaccine efficacy and especially about the catch-up vaccine (done after 15years old) are needed.

HPVAC2 is a prospective, analytic and monocentric study designed to learn the impact of the catch-up HPV vaccination.

Women from 25 years old and born after 1984 may be included if they come to the Brest CHU to do their regular cervical smear. At this time, a survey will be given to know their vaccinal status.

The aim of the study is to prove the efficacy of the catch up vaccination by analyzing the cervical smears results and by comparing the vaccinated group with the not-vaccinated group.

Enrollment: 354 patients

Sex: Female

Ages: 25 to 38 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Age limit
• Patient must have done a HPV or smear test during the study period
• Consent necessary

Exclusion criteria

• Age limit
• No HPV or smear test done in the study period
• Patient not able to give her consent

Trial design

354 participants in 2 patient groups

Vaccinated

Description:

Patients who have been vaccinated against HPV virus.

Not vaccinated

Description:

Patients who have not been vaccinated against HPV virus.